Program Overview
Please read the following program information before accessing the presentations using links located at the bottom of this page.
|
| Release Date: March 1, 2008 |
Expiration Date: February 28, 2009 |
Accreditation for Pharmacists:
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The program provides 2.0 hours (0.20 CEUs) of continuing education credit (Program Number 204-000-08-462-H01P). Upon successful completion of the online activity, participants may print their official ASHP CE statement. This activity is available for continuing education credit from March 1, 2008 through February 28, 2009.
Accreditation for Physicians:
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Health-System Pharmacists designates this educational activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Activity #: 08701. This program is available for continuing education credit from March 1, 2008 through February 28, 2009.
Accreditation for Nurses:
Educational Review Systems is an approved provider of continuing education in nursing by ASNA, an accredited provider by the ANCC/Commission on Accreditation. Provider #5-115-08-037. Educational Review Systems is also approved for nursing continuing education by the state of California and the District of Columbia. This activity is approved for 2.0 hours. Upon successful completion of the activity, participants may print their official CE statement. This program is available for continuing education credit from March 1, 2008 through February 28, 2009.
Methods and Format
This is an online activity consisting of audio, presentation slides, post-test, and an evaluation tool. Participant must view the entire presentation, take the activity post-test, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statement of continuing education credit immediately. The estimated time required to complete this activity is two hours. This activity is provided free of charge.
Target Audience
This continuing education activity was planned to meet the needs of pharmacists, physicians, nurses, blood bank personnel and others healthcare professionals who treat, instruct, or otherwise participate in the care of patients with bleeding or have an interest in transfusion medicine.
Activity Content
The therapeutic necessity for blood transfusions is well established; however, the transfusion of human plasma-derived components is not without drawbacks. There is significant expense associated with the testing, storage, and transfusion of blood products. Blood transfusions also pose a number of safety risks. The challenges and clinical shortcomings of blood transfusions have led clinicians to seek strategies to reduce blood transfusions. Those strategies include anemia management, blood conservation, the use of hemostatic agents and therapeutic alternatives to blood transfusion, and the development of hospital-specific transfusion guidelines.
There are many examples in the medical literature documenting improvements in patient care and health care resource utilization associated with the systematic development and institution-wide implementation of evidence-based, interdisciplinary treatment guidelines and protocols. These issues and other important topics in transfusion medicine will be addressed in this program.
Learning Objectives
After participating in this educational activity, participants should be able to:
- Discuss the current guidelines for the appropriate use of blood products, components, and therapeutic adjuncts.
- Explain the rationale and potential impact on patient care of applying current evidence and adjunctive therapies to transfusion protocols in the hospital setting.
- Discuss strategies for the successful development and implementation of transfusion guidelines or protocols.
Faculty
Jill A. Rebuck, Pharm.D., BCPS, FCCM
Program Chair
Critical Care Pharmacy Specialist
Lancaster General Hospital
Lancaster, Pennsylvania
Joseph Dasta, MS, FCCM, FCCP
Adjunct Professor of Pharmacy
University of Texas – Austin
Austin, Texas
Ira A. Shulman, M.D.
Professor, Vice Chair of Pathology and Director of Transfusion Medicine
Keck School of Medicine
University of Southern California and Director of Laboratories
LAC + USC Medical Center
Los Angeles, California
Disclosure Information
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships and that conflicts of interest be identified and resolved prior to delivery of the activity.
The faculty and planners report the following relationships:
Joseph Dasta, MS, FCCM, FCCP reports that he serves as a consultant for Ortho Biotech.
Jill A. Rebuck, Pharm.D., BCPS, FCCM reports that she has no relationships pertinent to this activity.
Ira A. Shulman, M.D. reports that he serves on a scientific advisory board for ImmucorGamma, a medical advisory board for Verax Biomedical, a scientific panel for Novo Nordisk, a hematology/pharmacy panel for Zymogenetics and in a consultation role for Chiron/Novartis.
Erika L. Thomas, M.B.A., R.Ph. declares that she has no relationships pertinent to this activity.
This activity is supported by an educational grant from Novo Nordisk.
Launch Presentation
If you would prefer a podcast format of this activity, click here.
Download Post-Test
Click here to print the post-test for your reference. Please note that to be eligible for continuing education credit, you must go to the ASHP Advantage Testing Center and complete the test online.
This activity is sponsored by the American Society of Health-System Pharmacists (ASHP) and planned by ASHP Advantage, a division of ASHP.